Effect of acetaminophen on the progression of renal damage in adenine induced renal failure model rats

Life Sciences

Volumn 91, Issue 25-26, 2012, Pages 1304-1308

  Kadowaki, Daisuke ^a   Sumikawa, Satomi ^a   Arimizu, Kanami ^a   Taguchi, Kazuaki ^a   Kitamura, Kenichiro ^b   Ishitsuka, Yoichi ^a   Narita, Yuki ^a   Irie, Tetsumi ^a   Chuang, Victor Tuan Giam ^c   Maruyama, Toru ^a   Otagiri, Masaki ^a,d   Hirata, Sumio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c CURTIN UNIVERSITY   (Australia)

^d SOJO UNIVERSITY   (Japan)

Author keywords

Acetaminophen; Adenine; Antioxidant; Metabolite; Renal failure

Indexed keywords

ADENINE; ADVANCED OXIDATION PROTEIN PRODUCT; GLUTATHIONE; INDOMETACIN; PARACETAMOL;

ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENUATION; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MEGADOSE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY INJURY; LOW DRUG DOSE; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; RAT; SURVIVAL RATE; TREATMENT DURATION;

ACETAMINOPHEN; ADENINE; ADMINISTRATION, ORAL; ANALGESICS, NON-NARCOTIC; ANIMALS; ANTIOXIDANTS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE; INDOMETHACIN; KIDNEY FAILURE, CHRONIC; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SURVIVAL RATE;

RATTUS;

EID: 84870297255     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.09.018     Document Type: Article

References (27)

1. A. Abdel-Zaher, M. Abdel-Rahman, M. Hafez, and F. Omran Role of nitric oxide and reduced glutathione in the protective effects of aminoguanidine, gadolinium chloride and oleanolic acid against acetaminophen-induced hepatic and renal damage Toxicology 234 2007 124 134
2. G. Bailie, N. Mason, J. Bragg-Gresham, B. Gillespie, and E. Young Analgesic prescription patterns among hemodialysis patients in the DOPPS: potential for underprescription Kidney Int 65 2004 2419 2425
3. B. Barrett Acetaminophen and adverse chronic renal outcomes: an appraisal of the epidemiologic evidence Am J Kidney Dis 28 1996 S14 S19
4. K. Bauerová, V. Nosál'ová, D. Mihalová, and J. Navarová Contribution to safe anti-inflammatory therapy with indomethacin Cent Eur J Public Health 12 2004 S8 S10 [Suppl.]
5. J.G. Bessems, and N.P. Vermeulen Paracetamol (acetaminophen)-induced toxicity: molecular and biochemical mechanisms, analogues and protective approaches Crit Rev Toxicol 31 2001 55 138
6. L.J. Brunner, and S. Bai Simple and rapid assay for acetaminophen and conjugated metabolites in low-volume serum samples J Chromatogr B Biomed Sci Appl 732 1999 323 329
7. M. Dani, J. Guindon, C. Lambert, and P. Beaulieu The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors Eur J Pharmacol 573 2007 214 215
8. K. Doi, and K. Ishida Diabetes and hypertriglyceridemia modify the mode of acetaminophen-induced hepatotoxicity and nephrotoxicity in rats and mice J Toxicol Sci 34 2009 1 11
9. A. Ghosh, and P. Sil Anti-oxidative effect of a protein from Cajanus indicus L against acetaminophen-induced hepato-nephro toxicity J Biochem Mol Biol 40 2007 1039 1049
10. Y. Ishima, T. Akaike, U. Kragh-Hansen, S. Hiroyama, T. Sawa, and T. Maruyama Effects of endogenous ligands on the biological role of human serum albumin in S-nitrosylation Biochem Biophys Res Commun 364 2007 790 795
11. L. James, S. McCullough, T. Knight, H. Jaeschke, and J. Hinson Acetaminophen toxicity in mice lacking NADPH oxidase activity: role of peroxynitrite formation and mitochondrial oxidant stress Free Radic Res 37 2003 1289 1297
12. M. Kurella, W. Bennett, and G. Chertow Analgesia in patients with ESRD: a review of available evidence Am J Kidney Dis 42 2003 217 228
13. C. Mallet, L. Daulhac, J. Bonnefont, C. Ledent, M. Etienne, and E. Chapuy Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia Pain 139 2008 190 200
14. U. Martin, R. Temple, R. Winney, and L. Prescott The disposition of paracetamol and the accumulation of its glucuronide and sulphate conjugates during multiple dosing in patients with chronic renal failure Eur J Clin Pharmacol 41 1991 43 46
15. M. Mazer, and J. Perrone Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management J Med Toxicol 4 2008 2 6
16. G. Merrill, and E. Goldberg Antioxidant properties of acetaminophen and cardioprotection Basic Res Cardiol 96 2001 423 430
17. S. Nelson, D. Dahlin, E. Rauckman, and G. Rosen Peroxidase-mediated formation of reactive metabolites of acetaminophen Mol Pharmacol 20 1981 195 199
18. R. Perlman, F. Finkelstein, L. Liu, E. Roys, M. Kiser, and G. Eisele Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD study Am J Kidney Dis 45 2005 658 666
19. L. Prescott, G. Speirs, J. Critchley, R. Temple, and R. Winney Paracetamol disposition and metabolite kinetics in patients with chronic renal failure Eur J Clin Pharmacol 36 1989 291 297
20. G. Rosen, W.J. Singletary, E. Rauckman, and P. Killenberg Acetaminophen hepatotoxicity. An alternative mechanism Biochem Pharmacol 32 1983 2053 2059
21. S. Schildknecht, A. Daiber, S. Ghisla, R. Cohen, and M. Bachschmid Acetaminophen inhibits prostanoid synthesis by scavenging the PGHS-activator peroxynitrite FASEB J 22 2008 215 224
22. K. Terai, K. Mizukami, and M. Okada Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model Nephrology (Carlton) 13 2008 139 146
23. K. Terai, H. Nara, K. Takakura, K. Mizukami, M. Sanagi, and S. Fukushima Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels Br J Pharmacol 156 2009 1267 1278
24. D. Tripathy, and P. Grammas Acetaminophen inhibits neuronal inflammation and protects neurons from oxidative stress J Neuroinflammation 6 2009 10
25. D. Tripathy, and P. Grammas Acetaminophen protects brain endothelial cells against oxidative stress Microvasc Res 77 2009 289 296
26. L. Trumper, L. Monasterolo, and M. Elías Nephrotoxicity of acetaminophen in male Wistar rats: role of hepatically derived metabolites J Pharmacol Exp Ther 279 1996 548 554
27. V. Witko-Sarsat, M. Friedlander, C. Capeillere-Blandin, T. Nguyen-Khoa, A.T. Nguyen, and J. Zingraff Advanced oxidation protein products as a novel marker of oxidative stress in uremia Kidney Int 49 1996 1304 1313